Filing Details
- Accession Number:
- 0001209191-20-049663
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-04 19:09:23
- Reporting Period:
- 2020-09-02
- Accepted Time:
- 2020-09-04 19:09:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1377832 | Matthew Strobeck | 9975 Summers Ridge Road San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-02 | 7,000 | $166.60 | 37,445 | No | 4 | P | Indirect | Birchview |
Common Stock | Acquisiton | 2020-09-02 | 300 | $167.74 | 37,745 | No | 4 | P | Indirect | Birchview |
Common Stock | Acquisiton | 2020-09-03 | 350 | $155.64 | 38,095 | No | 4 | P | Indirect | Birchview |
Common Stock | Acquisiton | 2020-09-03 | 50 | $155.60 | 38,145 | No | 4 | P | Indirect | Birchview |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Birchview |
No | 4 | P | Indirect | Birchview |
No | 4 | P | Indirect | Birchview |
No | 4 | P | Indirect | Birchview |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 16,630 | Indirect | UGMA Account |
Common Stock | 7,399 | Direct |
Footnotes
- The weighted average purchase price for these transactions was $166.5986 per share, with a range of $166.545 to $166.78 per share and were made by the Birchview Fund and Birchview Capital accounts. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
- The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Chief Executive Officer of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.